The relative role of patient physiology and device optimisation in cardiac resynchronisation therapy: A computational modelling study

Journal of Molecular and Cellular Cardiology

Volumn 96, Issue , 2016, Pages 93-100

  Crozier, Andrew ^a,b   Blazevic, Bojan ^a   Lamata, Pablo ^a   Plank, Gernot ^b   Ginks, Matthew ^c   Duckett, Simon ^c   Sohal, Manav ^c   Shetty, Anoop ^c   Rinaldi, Christopher A ^c   Razavi, Reza ^a   Smith, Nicolas P ^a,d   Niederer, Steven A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Cardiac resynchronisation therapy; Computational modelling; Dyssynchronous heart failure; Heart failure; Patient specific modelling

Indexed keywords

ANATOMIC MODEL; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CONGESTIVE CARDIOMYOPATHY; ELECTRIC CONDUCTIVITY; HEART AFTERLOAD; HEART CONDUCTION; HEART CONTRACTION; HEART EJECTION FRACTION; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE COMPLIANCE; HEART VOLUME; HUMAN; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; NERVE BLOCK; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REVIEW; SIMULATION; SINUS RHYTHM; AGED; BIOLOGICAL MODEL; CARDIAC MUSCLE; COMPUTER SIMULATION; FEMALE; HEART VENTRICLE FUNCTION; HEMODYNAMICS; MALE; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; COMPUTER SIMULATION; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MYOCARDIUM; VENTRICULAR DYSFUNCTION;

EID: 84947571645     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.10.026     Document Type: Review

References (40)

1. McMurray J.J.A., Pfeffer M.A. Heart failure. Lancet 2005, 365(9474):1877-1889.
2. Vardas P.E., Auricchio A., Blanc J.J., Daubert J.C., Drexler H., Ector H., et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. Eur. Heart J. 2007, 28(18):2256-2295.
3. Young J.B., Abraham W.T., Smith A.L., Leon A.R., Lieberman R., Wilkoff B., et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. J. Am. Med. Assoc. 2003, 289(20):2685-2694.
4. Daubert C., Gold M.R., Abraham W.T., Ghio S., Hassager C., Goode G., et al. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction insights: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left vEntricu- J. Am. Coll. Cardiol. 2009, 54(20):1837-1846.
5. National Institute for Health and Care Excellence (NICE) Implantable Cardioverter Defibrillators and Cardiac Resynchronisation Therapy for Arrhythmias and Heart Failure [TA314] 2014, NICE, London.
6. Abraham W.T., Fisher W.G., Smith A.L., Delurgio D.B., Leon A.R., Loh E., et al. Cardiac resynchronization in chronic heart failure. N. Engl. J. Med. 2002, 346(24):1845-1853.
7. Arshad A., Moss A.J., Foster E., Padeletti L., Barsheshet A., Goldenberg I., et al. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J. Am. Coll. Cardiol. 2011, 57(7):813-820.
8. Höke U., Thijssen J., van Bommel R.J., van Erven L., van der Velde E.T., Holman E.R., et al. Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapy. Diabetes Care 2013, 36(4):985-991.
9. McLeod C.J., Shen W.K., Rea R.F., Friedman P.A., Hayes D.L., Wokhlu A., et al. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy. Heart Rhythm. 2011, 8(3):377-382.
10. Dekker A.L.A.J., Phelps B., Dijkman B., van der Nagel T., van der Veen F.H., Geskes G.G., et al. Epicardial left ventricular lead placement for cardiac resynchronization therapy: optimal pace site selection with pressure-volume loops. J. Thorac. Cardiovasc. Surg. 2004, 127(6):1641-1647.
11. Singh J.P., Klein H.U., Huang D.T., Reek S., Kuniss M., Quesada A., et al. Left ventricular lead position and clinical outcome in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) Trial. Circulation 2011, 123(11):1159-1166.
12. Khan F.Z., Virdee M.S., Palmer C.R., Pugh P.J., O'Halloran D., Elsik M., et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J. Am. Coll. Cardiol. 2012, 59(17):1509-1518.
13. Hu Y., Gurev V., Constantino J., Trayanova N. Optimizing cardiac resynchronization therapy to minimize ATP consumption heterogeneity throughout the left ventricle: a simulation analysis using a canine heart failure model. Heart Rhythm. 2014, 11(6):1063-1069.
14. Krishnamurthy A., Villongco C.T., Chuang J., Frank L.R., Nigam V., Belezzuoli E., et al. Patient-specific models of cardiac biomechanics. J. Comput. Phys. 2013, 244:4-21.
15. Sermesant M., Chabiniok R., Chinchapatnam P., Mansi T., Billet F., Moireau P., et al. Patient-specific electromechanical models of the heart for the prediction of pacing acute effects in CRT: a preliminary clinical validation. Med. Image Anal. 2012, 16(1):201-215.
16. Niederer S.A., Plank G., Chinchapatnam P., Ginks M., Lamata P., Rhode K.S., et al. Length-dependent tension in the failing heart and the efficacy of cardiac resynchronization therapy. Cardiovasc. Res. 2011, 89(2):336-343.
17. Niederer S.A., Shetty A.K., Plank G., Bostock J., Razavi R., Smith N.P., et al. Biophysical modeling to simulate the response to multisite left ventricular stimulation using a quadripolar pacing lead. Pacing Clin. Electrophysiol. 2012, 35(2):204-214.
18. Niederer S.A., Smith N.P. An improved numerical method for strong coupling of excitation and contraction models in the heart. Prog. Biophys. Mol. Biol. 2008, 96(1-3):90-111.
19. ten Tusscher K.H.W.J., Panfilov A.V. Alternans and spiral breakup in a human ventricular tissue model. Am. J. Physiol. Heart Circ. Physiol. 2006, 291(3):H1088-H1100.
20. Guccione J.M., McCulloch A.D., Waldman L.K. Passive material properties of intact ventricular myocardium determined from a cylindrical model. J. Biomech. Eng. 1991, 113(1):42.
21. Lamata P., Niederer S., Nordsletten D., Barber D.C., Roy I., Hose D.R., et al. An accurate, fast and robust method to generate patient-specific cubic Hermite meshes. Med. Image Anal. 2011, 15(6):801-813.
22. Lamata P., Sinclair M., Kerfoot E., Lee A., Crozier A., Blazevic B., et al. An automatic service for the personalization of ventricular cardiac meshes. J. R. Soc. Interface 2014, 11(91):20131023.
23. Durrer D., van Dam R.T., Freud G.E., Janse M.J., Meijler F.L., Arzbaecher R.C. Total excitation of the isolated human heart. Circulation 1970, 41(6):899-912.
24. Rhode K.S., Sermesant M., Brogan D., Hegde S., Hipwell J., Lambiase P., et al. A system for real-time XMR guided cardiovascular intervention. IEEE Trans. Med. Imaging 2005, 24(11):1428-1440.
25. Duckett S.G., Ginks M., Shetty A.K., Bostock J., Gill J.S., Hamid S., et al. Invasive acute hemodynamic response to guide left ventricular lead implantation predicts chronic remodeling in patients undergoing cardiac resynchronization therapy. J. Am. Coll. Cardiol. 2011, 58(11):1128-1136.
26. Schilling R.J., Peters N.S., Davies D.W. Simultaneous endocardial mapping in the human left ventricle using a noncontact catheter: comparison of contact and reconstructed electrograms during sinus rhythm. Circulation 1998, 98(9):887-898.
27. Fung J.W.H., Chan J.Y.S., Yip G.W.K., Chan H.C.K., Chan W.W.L., Zhang Q., et al. Effect of left ventricular endocardial activation pattern on echocardiographic and clinical response to cardiac resynchronization therapy. Heart 2007, 93(4):432-437.
28. Ginks M.R., Shetty A.K., Lambiase P.D., Duckett S.G., Bostock J., Peacock J.L., et al. Benefits of endocardial and multisite pacing are dependent on the type of left ventricular electric activation pattern and presence of ischemic heart disease: insights from electroanatomic mapping. Circ. Arrhythm. Electrophysiol. 2012, 5(5):889-897.
29. Ramanathan C., Ghanem R.N., Jia P., Ryu K., Rudy Y. Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia. Nat. Med. 2004, 10(4):422-428.
30. Bogaard M.D., Houthuizen P., Bracke F.A., Doevendans P.A., Prinzen F.W., Meine M., et al. Baseline left ventricular dP/dtmax rather than the acute improvement in dP/dtmax predicts clinical outcome in patients with cardiac resynchronization therapy. Eur. J. Heart Fail. 2011, 13(10):1126-1132.
31. Prinzen F.W., Auricchio A. The "missing" link between acute hemodynamic effect and clinical response. J. Cardiovasc. Transl. Res. 2012, 5(2):188-195.
32. Derval N., Bordachar P., Lim H.S., Sacher F., Ploux S., Laborderie J., et al. Impact of pacing site on QRS duration and its relationship to hemodynamic response in cardiac resynchronization therapy for congestive heart failure. J. Cardiovasc. Electrophysiol. 2014, 25(9):1012-1020.
33. Gold M.R., Thébault C., Linde C., Abraham W.T., Gerritse B., Ghio S., et al. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) study. Circulation 2012, 126(7):822-829.
34. Molhoek S.G., VAN Erven L., Bootsma M., Steendijk P., Van Der Wall E.E., Schalij M.J. QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure. Pacing Clin. Electrophysiol. 2004, 27(3):308-313.
35. Yeim S., Bordachar P., Reuter S., Laborderie J., O'Neill M.D., Lafitte S., et al. Predictors of a positive response to biventricular pacing in patients with severe heart failure and ventricular conduction delay. Pacing Clin. Electrophysiol. 2007, 30(8):970-975.
36. Kass D.A., Chen C.H., Curry C., Talbot M., Berger R., Fetics B., et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999, 99(12):1567-1573.
37. Helm R.H., Byrne M., Helm P.A., Daya S.K., Osman N.F., Tunin R., et al. Three-dimensional mapping of optimal left ventricular pacing site for cardiac resynchronization. Circulation 2007, 115(8):953-961.
38. Butter C., Auricchio A., Stellbrink C., Fleck E., Ding J., Yu Y., et al. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001, 104(25):3026-3029.
39. Ginks M.R., Duckett S.G., Kapetanakis S., Bostock J., Hamid S., Shetty A., et al. Multi-site left ventricular pacing as a potential treatment for patients with postero-lateral scar: insights from cardiac magnetic resonance imaging and invasive haemodynamic assessment. Europace 2012, 14(3):373-379.
40. Auricchio A., Delnoy P.P., Butter C., Brachmann J., Van Erven L., Spitzer S., et al. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study. Europace 2014, 16(5):681-6818.